ArticleLaboratory medicine2026

HScore as a diagnostic tool in ERBB2 equivocal (immunohistochemistry 2+) breast cancer.

Tasnem Alsebai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.